Balyasny Asset Management LLC Cv Rx, Inc. Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
A detailed history of Balyasny Asset Management LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 344,165 shares of CVRX stock, worth $4.82 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
344,165
Previous 506,398
32.04%
Holding current value
$4.82 Million
Previous $4.46 Million
2.26%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
15.4MCall Options Held
76.5KPut Options Held
6.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$57.5 Million17.73% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$28.4 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$12.9 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$12.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$12.3 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $288M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...